By Bob Bohrer
An interesting development, reported in FiercePharma and originally by Reuters, on litigation between AbbVie and GlaxoSmithKline over AbbVie’s price increases on one of its combination drugs for HIV– the FiercePharma link is here.
Ruling in a suit over HIV-drug pricing protects gays’ right to sit on juries
